Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 5/2014

01-05-2014 | Editorial

Comment on Lun et al. entitled “The prognostic value of elevated ezrin in patients with osteosarcoma”

Authors: Zhi Li, Youjun Li

Published in: Tumor Biology | Issue 5/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Metadata
Title
Comment on Lun et al. entitled “The prognostic value of elevated ezrin in patients with osteosarcoma”
Authors
Zhi Li
Youjun Li
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1586-1

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue

Research Article

The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer

Research Article

Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation

Research Article

Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis

Research Article

RETRACTED ARTICLE: Lack of association of XRCC1 rs1799782 genetic polymorphism with risk of pancreatic cancer: a meta-analysis

Research Article

Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinoma

Research Article

Interleukin-6 −634C/G polymorphism is associated with lung cancer risk: a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits